Abstract
Allogeneic hematopoietic stem-cell transplantation (HSCT) from a matched related or unrelated donor can cure an adult with relapsed or high-risk acute myeloid leukemia (AML). However, because many of these patients lack a suitable donor, umbilical cord blood has been explored as a stem-cell source for transplantation. In a retrospective analysis of international transplantation registries, researchers identified …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
